MoneyWorks4Me

Indoco Remedies - Quaterly Results

16 May 2024 Evaluate
The total revenue for the quarter ended March 2024 remained nearly unchanged at Rs. 4454.90 millions.The company has announced a 48.05% increase in its profits to Rs . 375.60  millions for the  quarter ended March 2024 compared to Rs. 253.70 millions in the corresponding quarter in the previous year.A decline of 614.10 millions was observed in the OP in the quarter ended March 2024 from 646.60 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 4454.90 4274.60 4.22 17908.10 16666.90 7.45 17908.10 16666.90 7.45
Other Income 40.50 4.90 726.53 85.10 23.30 265.24 85.10 23.30 265.24
PBIDT 614.10 646.60 -5.03 2664.90 2872.20 -7.22 2664.90 2872.20 -7.22
Interest 109.10 86.40 26.27 368.20 250.30 47.10 368.20 250.30 47.10
PBDT 702.30 560.20 25.37 2412.00 2621.90 -8.01 2412.00 2621.90 -8.01
Depreciation 237.30 176.90 34.14 879.80 706.00 24.62 879.80 706.00 24.62
PBT 465.00 383.30 21.31 1532.20 1915.90 -20.03 1532.20 1915.90 -20.03
TAX 89.40 129.60 -31.02 365.80 502.30 -27.17 365.80 502.30 -27.17
Deferred Tax -15.20 6.10 -349.18 38.10 -49.70 -176.66 38.10 -49.70 -176.66
PAT 375.60 253.70 48.05 1166.40 1413.60 -17.49 1166.40 1413.60 -17.49
Equity 184.40 184.30 0.05 184.40 184.30 0.05 184.40 184.30 0.05
PBIDTM(%) 13.78 15.13 -8.87 14.88 17.23 -13.65 14.88 17.23 -13.65
Peers
Company Name CMP
Sun Pharma. Inds. 1756.90
Dr. Reddys Labs. 1195.10
Cipla 1303.30
Lupin 1960.00
Zydus Lifesciences 1115.10
View more..